Details of the Drug Formulaction

General Information of Drug Formulation (ID: F04493)

• Formulation Name: Clemastine 1.34 mg tablet
• Company: Novartis Consumer Health

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Clemastine	(DMBZWQL)	Allergic rhinitis	CA08.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant